SCHEMBL24813350

SCHEMBL24813350

c1ccc(-c2ccc(-c3ncnc(-c4ccc(-c5ccc6c(-c7ccc8ccccc8c7)c7ccccc7c(-c7ccc8ccccc8c7)c6c5)cc4)n3)cc2)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
PKM P14618 2/20 0.44
TSHR P16473 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HSD17B10 Q99714 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
KLF5 Q13887 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
SIRT2 Q8IXJ6 2/20 0.38
DHODH Q02127 1/20 0.38
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
DCTPP1 Q9H773 1/20 0.36
ABL1 P00519 1/20 0.35
HTR2B P41595 1/20 0.35
HTR5A P47898 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15977771 0.91 SMN1; SMN2 (0.48) KDM4ELMNAMAPTPKMTSHR
SCHEMBL24813356 0.91 NPC1 (0.45) KDM4ELMNAMAPTPKMTSHR
SCHEMBL24810523 0.90 TSHR (0.46) KDM4ELMNAMAPTPKMTSHR
SCHEMBL24811997 0.90 KDM4E (0.48) KDM4ELMNAMAPTPKMTSHR
SCHEMBL15977912 0.89 KDM4E (0.50) KDM4ELMNAMAPTPKMTSHR
SCHEMBL15977931 0.89 SMN1; SMN2 (0.48) KDM4ELMNAMAPTPKMTSHR
SCHEMBL24813347 0.88 SMN1; SMN2 (0.45) KDM4ELMNAMAPTPKMTSHR
SCHEMBL15977743 0.87 SMN1; SMN2 (0.42) KDM4ELMNAMAPTSMN1; SMN2HSD17B10
SCHEMBL10030057 0.87 SMN1; SMN2 (0.49) KDM4ELMNAMAPTPKMTSHR
SCHEMBL18431875 0.86 SMN1; SMN2 (0.44) KDM4ELMNAMAPTPKMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 KDM4E 3416/4885LMNA 1370/4885MAPT 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.